Target intelligence / Profile preview

Mitochondrial electron transport chain complexes I and III (ETC Complexes I and III)

Target
ETC Complexes I and III
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial respiratory chain complex
01

Overview

Mitochondrial electron transport chain (ETC) complexes I and III are essential multi-subunit enzymes located in the inner mitochondrial membrane that facilitate cellular respiration (Wikipedia, 2024). Complex I (NADH:ubiquinone oxidoreductase) and Complex III (ubiquinol-cytochrome c reductase) function sequentially to transfer electrons from NADH to cytochrome c, a process that drives the pumping of protons into the intermembrane space to establish the electrochemical gradient for ATP production (MDPI, 2021). These complexes are also the primary sites of reactive oxygen species (ROS) generation, making them central to both energy metabolism and oxidative stress signaling (NIH, 2021). In drug development, they are targeted to disrupt the bioenergetics of cancer cells (as 'mitocans') or to manage metabolic disorders, most notably through the Complex I inhibitor metformin (NIH, 2021; ResearchGate, 2021). However, their inhibition is associated with significant risks, including the development of lactic acidosis and neurodegenerative conditions, reflecting their vital role in maintaining cellular and systemic health (NIH, 2021; Wikipedia, 2021).

Other names
NADH:cytochrome c reductaseRespiratory chain complexes I and IIIComplex I and IIINADH dehydrogenase and Cytochrome bc1 complex
02

Mechanism of action

Inhibition of electron transfer within the mitochondrial respiratory chain, resulting in the depletion of ATP, accumulation of reactive oxygen species (ROS), and induction of the mitochondrial apoptotic pathway.

03

Biological functions

ATP synthesisOxidative phosphorylationReactive oxygen species productionApoptosisMetabolic homeostasis
04

Disease associations

CancerNeurodegenerative diseaseMitochondrial diseaseType 2 diabetesCardiovascular disease
05

Safety considerations

Lactic acidosisMitochondrial toxicityNeurotoxicityHepatotoxicityCardiotoxicity
06

Interacting drugs

Metformin

9 more in the full profile.

07

Biomarkers

LactatePyruvateLactate/Pyruvate ratioFibroblast growth factor 21 (FGF-21)Growth differentiation factor 15 (GDF-15)Oxygen consumption rate (OCR)Mitochondrial DNA (mtDNA) levels

Beyond the preview

Go deeper on Mitochondrial electron transport chain complexes I and III (ETC Complexes I and III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial electron transport chain complexes I and III (ETC Complexes I and III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call